Faculty of Allied Medical Science

Slides:



Advertisements
Similar presentations
Part 2 Terry Kotrla, MS, MT(ASCP)BB
Advertisements

TREATMENT Coagulopathy of Liver Failure. Fresh Frozen Plasma – Most effective way to correct hemostasis in patients with liver failure – Infusion (5-10mL/kg)
1. What is the sequence of the intrinsic pathway of coagulation?
What a Bloody Mess! A/Professor Kent Robinson Senior Staff Specialist, Liverpool & Campbelltown Hospitals.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.
-HA -HB -Factor XI deficiency -Factor II deficiency -Factor V deficiency -Factor XIII deficiency -Factor VII deficiency Dental problems in Hemophilia.
Blood Components Dosage And Their Administration
Blood Bank QEH- An era of bankruptcy?? Department of Haematology Dr. Renée Boyce Dr. Theresa Laurent (consultant/advisor)
Blood products By Dr Sarah Rehman Date: 10/10/14.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
BLOOD BANKING 1- BLOOD PRODUCTS 2- AUTOLOGOUS TRANSFUSION M. H. Shaheen Maadi Armed Forces Hospital.
Blood Components.
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.
1 Massive Blood Transfusion Massive transfusion, defined as the replacement by transfusion of more than 50 percent of a patient's blood volume in 12 to.
4th year medical students Blood Component Therapy Salwa I Hindawi MSc FRCPath CTM Director of Blood Transfusion Services KAUH. Jeddah.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
BLOOD TRANSFUSION Begashaw M (MD).
Hemostasis and Blood Coagulation
Transfusion of Blood Product History: 1920:Sodium citrate anticoagulant(10 days storage) 1958: Plastic bag of transfusion 1656: Initial theory and.
Principles of Hematology in Relation to Dental Management Dr. Saleh Al-Bazie, BDS, OMFS (USA), D.Sc.D, Consultant, OMFS, KSU, SHMC.
General Approach of Haemostasis
GURU BRAHMA GURU VISHNU GURU DEVO MAHESWARAHA GURU SHATHSHATH
CRYOPRECIPITATE USE IN 25 CANADIAN HOSPITALS: COMMONLY USED OUTSIDE OF THE PUBLISHED GUIDELINES Edward C Alport, Jeannie L Callum, Susan Nahirniak, Bernie.
BLOOD COMPONENT PREPARATION
BLOOD TRANSFUSION NUR 317. TRANSFUSION Infusion of blood products for the purpose of restoring circulating volume.
Blood Component Therapy
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.
UROOJ MUHAMMAD ISMAIL SYED ADNAN ALI WAHIDI NAJMA SOMROO NUZHAT HINA HINA KHAN SANAM QURBAN.
BLOOD TRANSFUSION Ms.SARITHA MOHAN B.Sc.(N) Nursing Eductor Al-Ahsa Hospital Kingdom of Saudi Arabia.
Module 1: The Journey of Blood: Donation to Distribution Transfusion Training Workshop KKM 2012.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Preparation of blood components
Anticoagulants and reversal
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
Blood Transfusion Safe Practice.
Von Willebrand’s Disease. vWD Family of bleeding disorders Family of bleeding disorders Caused by a deficiency or an abnormality of von Willebrand Factor.
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Blood Transfusion Products. Learning Objectives  To identify the products that can be derived from whole blood donations  To describe the conditions.
Abnormal bleeding in children J Kiwanuka. GENERAL INTRODUCTION.
Blood Transfusion Dr Dupe Elebute MD, MRCP, MRCPath
Chapter 17 Coagulation Testing
Management Control or elimination of the underlying cause Severe DIC: – Control of hemodynamic parameters – Respiratory support – Surgery Attempts to treat.
Chapter 23. Bleeding disorders associated with coagulopathy
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
Approach To Bleeding Disorders In Neonates
Blood Transfusions.
Prothrombin complex concentrate
K A U H Blood bank Wesaam Al-Sheyyab.
BLOOD & BLOOD PRODUCTS.
Transfusion Medicine: Types, Indications and Complications
Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
General Approach of Haemostasis
Warfarin Toxicity Treatment & Management
General Approach in Investigation of Hemostasis
BLOOD COMPONENTS Prepared by Emmanuel H. Ndaki Lab Scientist (components prep) Head of Lab, Lake Zone Blood Transfusion center Mwanza. 23 November 2017.
Prothrombin Complex Concentrate(PCC)
Laura Cooling MD, MS Associate Medical Director Transfusion Medicine
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
Hemophilia By: Renee Marie Alta.
Coagulation Disorders Importance in surgical practice
کزین برتر اندیشه بر نگذرد
Blood ,its products and transfusion
Blood Components Dosage And Their Administration
Presentation transcript:

Faculty of Allied Medical Science Blood Banking (MLBB 201)

HAEMOSTATIC COMPONENTS Prof.Dr. Nadia Aly Sadek Director of Blood Bank Centre – MRI University of Alexandria

ILOs By the end of this lecture, the students will be able to recognize; What is Fresh frozen plasma and cryoprecipitate.

Content

Fresh Frozen Plasma (FFP) 1 Fresh Frozen Plasma (FFP) Prepared from whole blood donation and frozen within 6 – 8 hours . It is stored at – 18o c or colder for up to 12 months. It contains: 91% water – 7% protein – 2% carbohydrate.

Fresh Frozen Plasma (FFP) 1 Fresh Frozen Plasma (FFP) Indications To treat prolonged PT or PTT Vitamin K deficiency and liver disease Dilutional coagulopathy Protein S, Protein C or Antithronbin deficiency.

Fresh Frozen Plasma (FFP) 1 Fresh Frozen Plasma (FFP) Thawing It should be thawed at temperature 30-37oc in a water bath. The unit should be wrapped in a plastic bag. Thawed FFP should be transfused immediately or within 12 hrs or stored between 1-6oc for no more than 12 hours. It should not be refrozen.

Fresh Frozen Plasma (FFP) 1 Fresh Frozen Plasma (FFP) Administration The same ABO as the protein. Given via a filter over 1 – 1.5 hours.

CRYOPRECIPITATE 2 Obtained from FFP and concentrated to 10 - 20 ml. It contains F VIII, (80 – 120 Units), v WF, 250 mg fibrinogen, 20 – 30% of factor XIII & fibronectin.

CRYOPRECIPITATE 2 Indications Factor VIII deficiency (Haemophilia A). Type II VW disease. Type I VW disease not responding to DDAVP. Factor XIII deficiency. Congenital fibrinogen abnormality.

CRYOPRECIPITATE 2 Indications When fibrinogen is ≤ 100 mg. Control of bleeding in uremic or hepatic patients. For preparation of fibrin glue: Topical use in orphopedic, ENT, dental, cardiac or neurological procedures. Reversal of warfarin overdose.

CRYOPRECIPITATE 2 Thawing It should be thawed at 37 0 c immediately before use and the pack should NOT be refrozen. Fibrinogen dose: 8 – 10 bags supply 2 g fibrinogen. Infusion Filter at rate of 1 – 2 ml/min.

2 CRYOPRECIPITATE Cryoprecipirate represents the cryoglobulin fraction of the plasma. It contains F VIII, VWF, fibrinogen, fibronectin and F XIII. It is used primarily for the treatment of Haemophilia A patients.

Platelet Concentrates 3 Platelet Concentrates Volume: 50 – 70 ml/unit provide about 5000 platelets. Kept at 20 – 22 0 c in a shaker for a maximum of 5 days. Should be infused within 4 hours, administered with filter

4 Prothrombin Complex This component contains prothrombin (F II), factor VII, F IX and factor X. It is lyophylized and virus-inactivated to reduce the risk of transmitting infections. Indications Haemophilia B (F IX deficiency). Serious coumarin overdosage together with Vitamin K1 Coagulation defects due to fulminant hepatitis or liver insufficiency.

5 FEIBA AND AUTOPLEX These are some activated prothrombin complex preparations used for treatment of Haemophilia A patients with inhibitors. These should be given with caution, as overuse may cause thrombosis and DIC. Currently, there are factors IX and F VII concentrates for TR of Haemophilia B.

6 Fibrin Glue It is formed by the reaction of cryo (fibrinogen) + thrombin as they are applied topically. Advantage Good hemostasis in different solid organ bleeding. Prevents post-operative bleeding. Efficient in the presence of coagulation defect and bacterial contamination.

Study Question Mention the indication of cryopercipitate.

Assignments Complication of blood transfusion محمد مصطفى محمد

THANK YOU